Avascular osteonecrosis in a young patient with a novel coronavirus infection
https://doi.org/10.47529/2223-2524.2022.2.3
Abstract
COVID‑19 continues demonstrating possible complications after recovery. One of these complications is avascular osteonecrosis, which can lead to bone destruction and patient disability. Cases of the development of osteonecrosis associated with coronavirus infection were widely reported during and after the SARS epidemic in 2003. They also appear to be common in COVID‑19 infection. All patients who have recovered from COVID‑19 infection, especially who received glucocorticoids, are threaten of osteonecrosis development.
We describe a case of bone necrosis in a healthy young woman without additional risk factors with a mild course of COVID, who received a short course of glucocorticoids.
This is the first described case of COVID‑induced osteonecrosis in our country, although due to the large‑scale use of glucocorticoids, there are probably more such cases. Early diagnosis is important to prevent disease progression. Therefore, clinical alertness is necessary in all patients with COVID‑19.
About the Authors
T. V. Kirsanova
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Russian Federation
Russian Federation
Tatiana V. Kirsanova, M.D., Ph.D., Leading Researcher of Institute of anestesiology‑resuscitation and transfusiology
4 Ac. Oparina str., Moscow, 117997
A. D. Meshkov
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Alexey D. Meshkov, M.D., Ph.D., Senior Researcher of the Laboratory of diseases of the musculoskeletal system, Russian Gerontology Research and Clinical Centre
16 1‑st Leonova str., Moscow, 129226
T. M. Manevich
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Tatiana M. Manevich, M.D., Ph.D., neurologist, Head of Neurological geriatric department of Russian Gerontology Research and Clinical Center
16 1‑st Leonova str., Moscow, 129226
M. А. Lysenko
Volgograd Regional Oncological Dispensary
Russian Federation
Russian Federation
Marina А. Lysenko, M.D., Ph.D., Head of Rehabilitation department for adults with somatic deceases
78 Zemlyachki str., Volgograd, 400138
References
1. Chalmers J.D., Crichton M.L., Goeminne P.C., Bin Cao, Humbert M., Shteinberg M., et al. Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur. Respir. J. 2021;57(4):2100048. https://doi.org/10.1183/13993003.00048-2021
2. Leung T.Y.M, Chan A.Y.L., Chan E.W., Chan V.K.Y., Chui C.S.L., Cowling B.J., et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg. Microbes Infect. 2020;9(1):2190–2199. https://doi.org/10.1080/22221751.2020.1825914
3. Mahase E. Covid-19: What do we know about “long covid”? BMJ 2020;370:m2815. doi:10.1136/bmj.m2815
4. Auyeung T.W., Lee J.S.W., Lai W.K., Choi C.H., Lee H.K., Lee J.S., et al. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J. Infect. 2005;51(2):98–102. https://doi.org/10.1016/j.jinf.2004.09.008
5. Xie L., Liu Y., Fan B., Xiao Y., Tian Q., Chen L., et al. Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir. Res. 2005;6(1):5. https://doi.org/10.1186/1465-9921-6-5
6. Jones J.P. Osteonecrosis. In: Koopman W.J., ed. Arthritis and allied conditions: a textbook of rheumatology. 14th edn. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001, pp. 2143–2164.
7. Anderton J.M., Helm R. Multiple joint osteonecrosis following short-term steroid therapy. Case report. J. Bone Joint Surg. Am. 1982;64:139–141. https://doi.org/10.2106/00004623-198264010-00020
8. McKee M.D., Waddell J.P., Kudo P.A., Schemitsch E.H., Richards R.R. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases. CMAJ. 2001;164(2):205–206.
9. Shigemura T., Nakamura J., Kishida S., Harada Y., Ohtori S., Kamikawa K., et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford). 2011;50(11):2023–2028. https://doi.org/10.1093/rheumatology/ker277
10. Gladman D.D., Chaudhry-Ahluwalia V., Ibañez D., et al. Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. J. Rheumatol. 2001;28(10):2226–2229.
11. Kamen D.L., Alele J.D. Skeletal manifestations of systemic autoimmune diseases. Curr. Opin. Endocrinol. Diabetes Obes. 2010;17(6):540–545. https://doi.org/10.1097/MED.0b013e328340533d
12. Jones J.P. Jr. Fat embolism and osteonecrosis. Orthop. Clin. North Am. 1985;16(4):595–633.
13. Solomon L. Idiopathic necrosis of the femoral head: pathogenesis and treatment. Can. J. Surg. 1981;24(6):573–578.
14. Nishimura T., Matsumoto T., Nishino M., Tomita K. Histopathologic study of veins in steroid treated rabbits. Clin. Orthop. Relat. Res 1997;334:37–42.
15. Dilisio M.F. Osteonecrosis following short-term, low-dose oral corticosteroids: a population-based study of 24 million patients. Orthopedics. 2014;37(7):e631–e636. https://doi.org/10.3928/01477447-20140626-54
16. Zizic T.M., Marcoux C., Hungerford D.S., Dansereau J.V., Stevens M.B. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am. J. Med 1985;79(5):596–604. https://doi.org/10.1016/0002-9343(85)90057-9
17. Abeles M., Urman J.D., Rothfield N.F. Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch. Intern. Med 1978;138(5):750–754.
18. Zhao F.C., Guo K.J., Li Z.R. Osteonecrosis of the femoral head in SARS patients: seven years later. Eur. J. Orthop. Surg. Traumatol. 2013;23(6): 671–677. https://doi.org/10.1007/s00590-012-1054-4
19. Mirzai R., Chang C., Greenspan A., Gershwin M.E. The pathogenesis of osteonecrosis and the relationships to corticosteroids. J. Asthma. 1999;36(1):77–95. https://doi.org/10.3109/02770909909065152
20. Assouline-Dayan Y., Chang C., Greenspan A., Filella X., Trejo O, de la Red G., et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002;32(1):94–124. https://doi.org/10.1053/sarh.2002.33724
21. Agarwala S.R., Vijayvargiya M., Pandey P. Avascular necrosis as a part of ‘long COVID-19’. BMJ Case Rep. 2021;14(7):e242101. https://doi.org/10.1136/bcr-2021-242101
22. Hong N., Du X.K. Avascular necrosis of bone in severe acute respiratory syndrome. Clin. Radiol. 2004;59(7):602–608. https://doi.org/10.1016/j.crad.2003
23. Griffith J.F. Musculoskeletal complications of severe acute respiratory syndrome. Semin. Musculoskelet. Radiol. 2011;15(5):554–560. https://doi.org/10.1055/s-0031-1293500
24. Lau E.M.C., Chan F.W.K., Hui D.S.C., Wu A.K.L., Leung P.C. Reduced bone mineral density in male severe acute respiratory syndrome (SARS) patients in Hong Kong. Bone. 2005;37(3):420–424. https://doi.org/10.1016/j.bone.2005.04.018
25. Disser N.P., De Micheli A.J., Schonk M.M. et al. Musculoskeletal Consequences of COVID-19. J. Bone Joint Surg. Am. 2020;102(14):1197–1204. https://doi.org/10.2106/JBJS.20.00847
26. Gralinski L.E., Ferris M.T., Aylor D.L., Whitmore A.C., Green R., Frieman M.B., et al. Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross. PLoS Genet. 2015;11(10):e1005504. https://doi.org/10.1371/journal.pgen.1005504
27. Kerachian M.A., Harvey E.J., Cournoyer D., Chow T.Y.K., Séguin C. Avascular Necrosis of the Femoral Head: Vascular Hypotheses. Endothelium. 2006;13(4):237–244. https://doi.org/10.1080/10623320600904211.
28. Veyre F., Poulain-Veyre C., Esparcieux A., Monsarrat N., Aouifi A., Lapeze J., Chatelard P. Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19. Ann. Vasc. Surg. 2020;69:85–88. https://doi.org/10.1016/j.avsg.2020.07.013
29. Escher R., Breakey N., Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thrombosis Research. 2020;190:62. https://doi.org/10.1016/j.thromres.2020.04.014
30. Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-5
31. Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020;383(2):120–128. https://doi.org/10.1056/NEJMoa2015432
32. Huertas A., Montani D., Savale L., Pichon J., Tu L., Parent F., et al. Endothelial cell dysfunction: a major player in SARSCoV-2 infection (COVID-19)?. Eur. Respiratory Soc. 2020;56(1):2001634. https://doi.org/10.1183/13993003.01634-2020
33. Mangwani J., Boksh K., Houchen-Wolloff L., Asif A., Mangwani N. Stress Fractures: A Growing Concern during the COVID-19 Pandemic. Journal of Foot and Ankle Surgery (Asia Pacific). 2021;8(2):80–85. https://doi.org/10.5005/jp-journals-10040-1157
34. Bezuglov E.N., Lyubushkina A.V., Kirsanova T.V. Stress injuries of bone tissue in sports. Moscow: GEOTAR-Media Publ; 2021 (In Russ.).
35. Agarwala S., Shah S., Joshi V.R. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. J. Bone Joint Surg. Br. 2009;91(8):1013–1018. https://doi.org/10.1302/0301-620X.91B8.21518
36. Agarwala S., Banavali S.D., Vijayvargiya M. Bisphosphonate combination therapy in the management of Postchemotherapy avascular necrosis of the femoral head in adolescents and young adults: a retrospective study from India. J. Glob. Oncol 2018;4:1–11. https://doi.org/10.1200/JGO.17.00083
37. Gupta S., Gupta H., Mandhyan D., Srivastava S. Bisphophonates related osteonecrosis of the jaw. Natl. J. Maxillofac Surg. 2013;4(2):151–158. https://doi.org/10.4103/0975-5950.127643
38. Chen C.H., Chang J.K., Lai K.A., Hou S.-M., Chang C.-H., Wang G.-J. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2012;64(5):1572–1578. https://doi.org/10.1002/art.33498
39. Yuan H.F., Guo C.A., Yan Z.Q. The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials. Osteoporos Int. 2016;27(1):295–299. https://doi.org/10.1007/s00198-015-3317-5
40. Aspenberg P., Johansson T. Teriparatide improves early callus formation in distal radial fractures. Acta Orthop. 2010;81(2):234–236. https://doi.org/10.3109/17453671003761946
41. Gende A., Thomsen T.W., Marcussen B., Hettrich C. Delayed-Union of Acetabular Stress Fracture in Female Gymnast: Use of Teriparatide to Augment Healing. Clin. J. Sport Med. 2020;30(5):e163–e165. https://doi.org/10.1097/JSM.0000000000000739
Review
For citations:
Kirsanova T.V., Meshkov A.D., Manevich T.M., Lysenko M.А. Avascular osteonecrosis in a young patient with a novel coronavirus infection. Sports medicine: research and practice. 2022;12(2):32-39. (In Russ.) https://doi.org/10.47529/2223-2524.2022.2.3
Views:
550
Email this article 